Tapewire

Nasdaq · USD

PTGX

Protagonist Therapeutics, Inc

Export transactions ↓
Tapewire entity
3552
SEC CIK
0001377121
Parsed reports
275

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 2026012
Feb 202602
Mar 202605
Apr 202601
May 202607
Jun 202602
Jul 202600
Aug 202602
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 09, 2024 Filed Jan 12, 2024 01:00 UTC
Gupta SuneelChief Development Officer
SaleCommon Stock 5,000 $25.00 $125,000.00
Disclosure

SEC source: 0001104659-24-003435 · tm243091-1_4seq1.xml · nonDerivative · entry 2

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,567

F1 · kind: Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 25, 2023.

Read SEC document
January 09, 2024 Filed Jan 12, 2024 01:00 UTC
Gupta SuneelChief Development Officer
Exercise / conversionCommon Stock 5,000 $7.38 $36,900.00
Disclosure

SEC source: 0001104659-24-003435 · tm243091-1_4seq1.xml · nonDerivative · entry 1

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,567

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:11 UTC
PATEL DINESH V PH DDirector · President and CEO
GrantStock Option (right to buy) · Derivative 315,250 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001492 · tm241954-4_4seq1.xml · derivative · entry 2

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,250

Underlying: Common Stock · 315,250 shares

Expires 2034-01-02

F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:11 UTC
PATEL DINESH V PH DDirector · President and CEO
GrantCommon Stock 84,875 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-001492 · tm241954-4_4seq1.xml · nonDerivative · entry 1

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 619,222

F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:07 UTC
Ali AsifChief Financial Officer
GrantStock Option (right to buy) · Derivative 78,000 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001489 · tm241954-1_4seq1.xml · derivative · entry 2

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,000

Underlying: Common Stock · 78,000 shares

Expires 2034-01-02

F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:07 UTC
Ali AsifChief Financial Officer
GrantCommon Stock 21,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-001489 · tm241954-1_4seq1.xml · nonDerivative · entry 1

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,036

F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 20:17 UTC GrantStock Option (right to buy) · Derivative 25,700 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001496 · tm241954-8_4seq1.xml · derivative · entry 1

O'Dowd Sarah A · CIK 0001447149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,700

Underlying: Common Stock · 25,700 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:17 UTC GrantStock Option (right to buy) · Derivative 25,700 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001497 · tm241954-9_4seq1.xml · derivative · entry 1

Waddill William D. · CIK 0001553338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,700

Underlying: Common Stock · 25,700 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:15 UTC
Gupta SuneelChief Development Officer
GrantStock Option (right to buy) · Derivative 71,500 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001495 · tm241954-7_4seq1.xml · derivative · entry 2

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,500

Underlying: Common Stock · 71,500 shares

Expires 2034-01-02

F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:15 UTC
Gupta SuneelChief Development Officer
GrantCommon Stock 19,250 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-001495 · tm241954-7_4seq1.xml · nonDerivative · entry 1

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,567

F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:14 UTC GrantStock Option (right to buy) · Derivative 25,700 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001494 · tm241954-6_4seq1.xml · derivative · entry 1

Williams Lewis T · CIK 0001475714 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,700

Underlying: Common Stock · 25,700 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:13 UTC GrantStock Option (right to buy) · Derivative 25,700 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001493 · tm241954-5_4seq1.xml · derivative · entry 1

SELICK HAROLD E · CIK 0001287233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,700

Underlying: Common Stock · 25,700 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:10 UTC GrantStock Option (right to buy) · Derivative 25,700 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001491 · tm241954-3_4seq1.xml · derivative · entry 1

Giraudo Bryan · CIK 0001740847 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,700

Underlying: Common Stock · 25,700 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:09 UTC
MOLINA ARTURO MDChief Medical Officer
GrantStock Option (right to buy) · Derivative 97,500 $0.00 Strike: $23.42 $0.00
Disclosure

SEC source: 0001104659-24-001490 · tm241954-2_4seq1.xml · derivative · entry 3

MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,500

Underlying: Common Stock · 97,500 shares

Expires 2034-01-02

F3 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 01:09 UTC
MOLINA ARTURO MDChief Medical Officer
GrantCommon Stock 26,250 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-001490 · tm241954-2_4seq1.xml · nonDerivative · entry 2

MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,777

F2 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:30 UTC
PATEL DINESH V PH DDirector · President and CEO
SaleCommon Stock 75,000 $20.08 $1,506,000.00
Disclosure

SEC source: 0001104659-23-126419 · tm2333032-1_4seq1.xml · nonDerivative · entry 1

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 534,347

F1 · kind: Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 20, 2023.

F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.20. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 15, 2023 Filed Jan 5, 2024 01:09 UTC
MOLINA ARTURO MDChief Medical Officer
SaleCommon Stock 1,848 $16.24 $30,011.52
Disclosure

SEC source: 0001104659-24-001490 · tm241954-2_4seq1.xml · nonDerivative · entry 1

MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,527

F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

Read SEC document
October 26, 2023 Filed Oct 30, 2023 20:31 UTC GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $14.21 $0.00
Disclosure

SEC source: 0001104659-23-112599 · tm2328975-3_4seq1.xml · derivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-10-26

F1 · derivative.exercise_date: The options vest in 36 equal monthly installments following October 26, 2023, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
October 19, 2023 Filed Oct 23, 2023 20:31 UTC
Gupta SuneelChief Development Officer
Exercise / conversionStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $7.38 $0.00
Disclosure

SEC source: 0001104659-23-110803 · tm2328975-1_4seq1.xml · derivative · entry 2

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 20,000 shares

Expires 2029-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options are fully vested.

Read SEC document
October 19, 2023 Filed Oct 23, 2023 20:31 UTC
Gupta SuneelChief Development Officer
Exercise / conversionCommon Stock 20,000 $7.38 $147,600.00
Disclosure

SEC source: 0001104659-23-110803 · tm2328975-1_4seq1.xml · nonDerivative · entry 1

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 280 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023.

Read SEC document
October 18, 2023 Filed Oct 19, 2023 20:55 UTC
PATEL DINESH V PH DDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,000 $0.00 Strike: $4.21 $0.00
Disclosure

SEC source: 0001104659-23-110157 · tm2328807-1_4seq1.xml · derivative · entry 2

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 6,000 shares

Expires 2026-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options are fully vested.

Read SEC document
October 18, 2023 Filed Oct 19, 2023 20:55 UTC
PATEL DINESH V PH DDirector · President and CEO
Exercise / conversionCommon Stock 6,000 $4.21 $25,260.00
Disclosure

SEC source: 0001104659-23-110157 · tm2328807-1_4seq1.xml · nonDerivative · entry 1

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 609,347

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 401 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:50 UTC
PATEL DINESH V PH DDirector · President and CEO
Tax withholdingCommon Stock 12,165 $26.07 $317,141.55
Disclosure

SEC source: 0001104659-23-067690 · tm2317724-2_4seq1.xml · nonDerivative · entry 3

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 602,946

F4 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of PSUs.

F1 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:50 UTC
PATEL DINESH V PH DDirector · President and CEO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-067690 · tm2317724-2_4seq1.xml · nonDerivative · entry 2

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 615,111

F2 · shares: Represents settlement by the Issuer of performance stock units ("PSUs") granted to the Reporting Person under the Company's 2016 Equity Incentive Plan on May 31, 2022, which vested based on the Issuer's achievement of corporate performance objectives.

F1 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

F3 · balance_after: Includes an aggregate of 1,663 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:48 UTC
Ali AsifChief Financial Officer
Tax withholdingCommon Stock 4,150 $26.07 $108,190.50
Disclosure

SEC source: 0001104659-23-067689 · tm2317724-1_4seq1.xml · nonDerivative · entry 2

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,036

F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of PSUs.

F2 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:48 UTC
Ali AsifChief Financial Officer
GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-067689 · tm2317724-1_4seq1.xml · nonDerivative · entry 1

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,186

F1 · shares: Represents settlement by the Issuer of performance stock units ("PSUs") granted to the Reporting Person under the Company's 2016 Equity Incentive Plan on May 31, 2022, which vested based on the Issuer's achievement of corporate performance objectives.

F2 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:51 UTC
Gupta SuneelChief Development Officer
Tax withholdingCommon Stock 4,150 $26.07 $108,190.50
Disclosure

SEC source: 0001104659-23-067691 · tm2317724-3_4seq1.xml · nonDerivative · entry 2

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,037

F4 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of PSUs.

F2 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:51 UTC
Gupta SuneelChief Development Officer
GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-067691 · tm2317724-3_4seq1.xml · nonDerivative · entry 1

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,187

F1 · shares: Represents settlement by the Issuer of performance stock units ("PSUs") granted to the Reporting Person under the Company's 2016 Equity Incentive Plan on May 31, 2022, which vested based on the Issuer's achievement of corporate performance objectives.

F2 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

F3 · balance_after: Includes an aggregate of 2,000 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2023.

Read SEC document
April 18, 2023 Filed Apr 19, 2023 20:28 UTC
Ali AsifChief Financial Officer
Tax withholdingCommon Stock 1,189 $23.21 $27,596.69
Disclosure

SEC source: 0001104659-23-047208 · tm2312473-2_4seq1.xml · nonDerivative · entry 1

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,186

F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 3,437 vested restricted stock units on April 18, 2023.

F2 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
April 10, 2023 Filed Apr 11, 2023 23:18 UTC Exercise / conversionStock Option (right to buy) · Derivative 6,196 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001104659-23-044168 · tm2312473-1_4seq.xml · derivative · entry 2

SELICK HAROLD E · CIK 0001287233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,196 shares

Expires 2023-09-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is vested in full.

Read SEC document
April 10, 2023 Filed Apr 11, 2023 23:18 UTC Exercise / conversionCommon Stock 6,196 $0.87 $5,390.52
Disclosure

SEC source: 0001104659-23-044168 · tm2312473-1_4seq.xml · nonDerivative · entry 1

SELICK HAROLD E · CIK 0001287233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,506

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
February 22, 2023 Filed Jun 2, 2023 23:50 UTC
PATEL DINESH V PH DDirector · President and CEO
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-067690 · tm2317724-2_4seq1.xml · nonDerivative · entry 1

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 583,448

F1 · balance_after: The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:48 UTC
PATEL DINESH V PH DDirector · President and CEO
GrantStock Option (right to buy) · Derivative 600,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004721 · tm233829-7_4.xml · derivative · entry 3

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2033-01-15

F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:53 UTC
Ali AsifChief Financial Officer
GrantStock Option (right to buy) · Derivative 63,750 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004725 · tm233829-3_4seq1.xml · derivative · entry 2

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 63,750 shares

Expires 2033-01-15

F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:53 UTC
Ali AsifChief Financial Officer
GrantCommon Stock 10,625 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-004725 · tm233829-3_4seq1.xml · nonDerivative · entry 1

Ali Asif · CIK 0001921163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,375

F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026.

Read SEC document
January 16, 2023 Filed Jan 18, 2023 20:03 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004734 · tm233829-1_4seq1.xml · derivative · entry 1

Noonberg Sarah B. · CIK 0001706301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 18, 2023 20:00 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004732 · tm233829-2_4seq1.xml · derivative · entry 1

O'Dowd Sarah A · CIK 0001447149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 01:10 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004737 · tm233829-9_4seq1.xml · derivative · entry 1

Williams Lewis T · CIK 0001475714 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:58 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004731 · tm233829-10_4seq1.xml · derivative · entry 1

SELICK HAROLD E · CIK 0001287233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 01:07 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004735 · tm233829-4_4seq1.xml · derivative · entry 1

Waddill William D. · CIK 0001553338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 01:13 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004739 · tm233829-6_4seq1.xml · derivative · entry 1

Giraudo Bryan · CIK 0001740847 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:56 UTC
Gupta SuneelChief Development Officer
GrantStock Option (right to buy) · Derivative 123,750 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004730 · tm233829-8_4seq1.xml · derivative · entry 2

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,750

Underlying: Common Stock · 123,750 shares

Expires 2033-01-15

F3 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:56 UTC
Gupta SuneelChief Development Officer
GrantCommon Stock 20,625 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-004730 · tm233829-8_4seq1.xml · nonDerivative · entry 1

Gupta Suneel · CIK 0001763923 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,187

F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026.

F2 · balance_after: Includes 1 share acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2022.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:51 UTC
MOLINA ARTURO MDChief Medical Officer
GrantStock Option (right to buy) · Derivative 18,750 $0.00 Strike: $12.17 $0.00
Disclosure

SEC source: 0001104659-23-004722 · tm233829-5_4seq1.xml · derivative · entry 2

MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Stock · 18,750 shares

Expires 2033-01-15

F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant.

Read SEC document
January 16, 2023 Filed Jan 19, 2023 00:51 UTC
MOLINA ARTURO MDChief Medical Officer
GrantCommon Stock 3,125 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-004722 · tm233829-5_4seq1.xml · nonDerivative · entry 1

MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,375

F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026.

Read SEC document
December 28, 2022 Filed Jan 19, 2023 00:48 UTC
PATEL DINESH V PH DDirector · President and CEO
GiftCommon Stock 3,116 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-004721 · tm233829-7_4.xml · nonDerivative · entry 2

PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598,096

F1 · balance_after: Includes an aggregate of 164 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2022.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 23:24 UTC
Liu David YChief R&D Strategy Officer
Exercise / conversionStock Option (right to buy) · Derivative 35,331 $0.00 Strike: $4.21 $0.00
Disclosure

SEC source: 0001104659-22-119974 · tm2230775-3_4seq1.xml · derivative · entry 10

Liu David Y · CIK 0001675881 · Chief R&D Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,331 shares

Expires 2026-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is vested in full.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 23:24 UTC
Liu David YChief R&D Strategy Officer
Exercise / conversionStock Option (right to buy) · Derivative 35,656 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001104659-22-119974 · tm2230775-3_4seq1.xml · derivative · entry 9

Liu David Y · CIK 0001675881 · Chief R&D Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,656 shares

Expires 2025-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is vested in full.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 23:24 UTC
Liu David YChief R&D Strategy Officer
Exercise / conversionStock Option (right to buy) · Derivative 5,999 $0.00 Strike: $1.89 $0.00
Disclosure

SEC source: 0001104659-22-119974 · tm2230775-3_4seq1.xml · derivative · entry 8

Liu David Y · CIK 0001675881 · Chief R&D Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,999 shares

Expires 2025-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is vested in full.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 23:24 UTC
Liu David YChief R&D Strategy Officer
Exercise / conversionStock Option (right to buy) · Derivative 9,726 $0.00 Strike: $1.89 $0.00
Disclosure

SEC source: 0001104659-22-119974 · tm2230775-3_4seq1.xml · derivative · entry 7

Liu David Y · CIK 0001675881 · Chief R&D Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,726 shares

Expires 2024-10-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is vested in full.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.